Dan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Dan Liu has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Jason G. Cyster
Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA
4 shared publications Jinping An
3 shared publications- Mark R. Looney
University of California, San Francisco
3 shared publications Ying Xu
3 shared publications- Longhui Qiu
Department of Medicine, University of California, San Francisco, CA
2 shared publications - Alexander Marson
University of California, San Francisco 1 Department of Medicine San Francisco, California
1 shared publication
Latest Publications
- Open Access
- 8 July 2026
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1)
CXCL13⁺ CD4⁺ T cells are associated with B-cell recruitment and lesion progression in cerebral cavernous malformations
Cerebral cavernous malformations (CCMs) are neurovascular abnormalities associated with lifelong risks of intracranial hemorrhage (ICH), seizures, and neurologic deficits, affecting approximately 0.16%~0.8% of the general population. Although immune cell infiltration is well recognized as promoting CCM progression, the mechanisms underlying their recruitment into the lesion microenvironment remain poorly understood. In our study, we employed single-cell RNA sequencing (scRNA-seq) to identify a significant enrichment of a CD4⁺ T-cell subset producing CXCL13 and decipher the cellular crosstalk within CCMs. The CXCL13-producing CD4⁺ T cells exhibited enhanced interaction with CXCR5⁺ memory B cells, which showed upregulation of genes related to activation, persistence, and targeted migration. Immunohistochemical staining supported the spatial co-localization between CXCL13⁺ CD4⁺ T cells and CXCR5⁺ CD20⁺ B cells, as well as a positive association between their abundances, reinforcing this cellular crosstalk and suggesting a potential role for CXCL13 in shaping the inflammatory microenvironment and local adaptive immune responses. Clinically, elevated CXCL13 expression in CCM lesions was associated with a higher frequency of subacute ICH and B-cell infiltration in patients. Finally, in vivo experiments showed that administration of recombinant CXCL13 increased B-cell infiltration and Prussian blue staining-defined lesion bleeding, whereas blockade of CXCL13 attenuated CCM lesion development. Thus, our study identified a potentially pathogenic CXCL13+ CD4+ T-cell subset in CCMs, providing a rationale for targeting CXCL13 signaling in CCMs.
- 8 July 2026
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 23 (1)
Open AccessCXCL13⁺ CD4⁺ T cells are associated with B-cell recruitment and lesion progression in cerebral cavernous malformations
Cerebral cavernous malformations (CCMs) are neurovascular abnormalities associated with lifelong risks of intracranial hemorrhage (ICH), seizures, and neurologic deficits, affecting approximately 0.16%~0.8% of the general population. Although immune cell infiltration is well recognized as promoting CCM progression, the mechanisms underlying their recruitment into the lesion microenvironment remain poorly understood. In our study, we employed single-cell RNA sequencing (scRNA-seq) to identify a significant enrichment of a CD4⁺ T-cell subset producing CXCL13 and decipher the cellular crosstalk within CCMs. The CXCL13-producing CD4⁺ T cells exhibited enhanced interaction with CXCR5⁺ memory B cells, which showed upregulation of genes related to activation, persistence, and targeted migration. Immunohistochemical staining supported the spatial co-localization between CXCL13⁺ CD4⁺ T cells and CXCR5⁺ CD20⁺ B cells, as well as a positive association between their abundances, reinforcing this cellular crosstalk and suggesting a potential role for CXCL13 in shaping the inflammatory microenvironment and local adaptive immune responses. Clinically, elevated CXCL13 expression in CCM lesions was associated with a higher frequency of subacute ICH and B-cell infiltration in patients. Finally, in vivo experiments showed that administration of recombinant CXCL13 increased B-cell infiltration and Prussian blue staining-defined lesion bleeding, whereas blockade of CXCL13 attenuated CCM lesion development. Thus, our study identified a potentially pathogenic CXCL13+ CD4+ T-cell subset in CCMs, providing a rationale for targeting CXCL13 signaling in CCMs.
- 15 May 2026
- Published by Elsevier in Current Opinion in Immunology
- Vol. 101, 102788
Dendritic cell homeostasis in the splenic microenvironment
- 15 May 2026
- Published by Elsevier in Current Opinion in Immunology
- Vol. 101, 102788
Dendritic cell homeostasis in the splenic microenvironment
- 29 May 2025
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-13
Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants
Small-molecule-binding proteins can neutralize toxins and cytotoxic drugs, but their development is hindered by unpredictable in vivo behaviour and the poor immunogenicity of small molecules, which limits antibody-based approaches. Here we present a strategy to engineer de novo-designed proteins for the effective clearance of Food and Drug Administration-approved drugs in healthy mice. As a proof of concept, we designed proteins that bind to the anticoagulant apixaban. Since apixaban lacks chirality, we used mirror-image synthesis and cyclization to enhance the designed protein’s in vivo stability. Both protein variants demonstrated effective activity, facilitating the rapid clearance of apixaban within 30 min. To assess the broader applicability of this approach, we extended our analysis to a de novo-designed protein targeting the anticancer drug rucaparib, further confirming its potential for small-molecule clearance. Our study shows that de novo-designed small-molecule-binding proteins can be used as antidotes in vivo, and that computational tools can be integrated with medicinal chemistry strategies for precise pharmacological interventions.
- 29 May 2025
- Published by Springer Nature in Nature Biomedical Engineering
- p. 1-13
Rapid clearance of achiral small-molecule drugs using de novo-designed proteins and their cyclic and mirror-image variants
Small-molecule-binding proteins can neutralize toxins and cytotoxic drugs, but their development is hindered by unpredictable in vivo behaviour and the poor immunogenicity of small molecules, which limits antibody-based approaches. Here we present a strategy to engineer de novo-designed proteins for the effective clearance of Food and Drug Administration-approved drugs in healthy mice. As a proof of concept, we designed proteins that bind to the anticoagulant apixaban. Since apixaban lacks chirality, we used mirror-image synthesis and cyclization to enhance the designed protein’s in vivo stability. Both protein variants demonstrated effective activity, facilitating the rapid clearance of apixaban within 30 min. To assess the broader applicability of this approach, we extended our analysis to a de novo-designed protein targeting the anticancer drug rucaparib, further confirming its potential for small-molecule clearance. Our study shows that de novo-designed small-molecule-binding proteins can be used as antidotes in vivo, and that computational tools can be integrated with medicinal chemistry strategies for precise pharmacological interventions.
- Open Access
- 19 February 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (5)
Intravital imaging of pulmonary lymphatics in inflammation and metastatic cancer
Intravital microscopy has enabled the study of immune dynamics in the pulmonary microvasculature, but many key events remain unseen because they occur in deeper lung regions. We therefore developed a technique for stabilized intravital imaging of bronchovascular cuffs and collecting lymphatics surrounding pulmonary veins in mice. Intravital imaging of pulmonary lymphatics revealed ventilation dependence of steady-state lung lymph flow and ventilation-independent lymph flow during inflammation. We imaged the rapid exodus of migratory dendritic cells through lung lymphatics following inflammation and measured effects of pharmacologic and genetic interventions targeting chemokine signaling. Intravital imaging also captured lymphatic immune surveillance of lung-metastatic cancers and lymphatic metastasis of cancer cells. To our knowledge, this is the first imaging of lymph flow and leukocyte migration through intact pulmonary lymphatics. This approach will enable studies of protective and maladaptive processes unfolding within the lungs and in other previously inaccessible locations.
- 19 February 2025
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (5)
Open AccessIntravital imaging of pulmonary lymphatics in inflammation and metastatic cancer
Intravital microscopy has enabled the study of immune dynamics in the pulmonary microvasculature, but many key events remain unseen because they occur in deeper lung regions. We therefore developed a technique for stabilized intravital imaging of bronchovascular cuffs and collecting lymphatics surrounding pulmonary veins in mice. Intravital imaging of pulmonary lymphatics revealed ventilation dependence of steady-state lung lymph flow and ventilation-independent lymph flow during inflammation. We imaged the rapid exodus of migratory dendritic cells through lung lymphatics following inflammation and measured effects of pharmacologic and genetic interventions targeting chemokine signaling. Intravital imaging also captured lymphatic immune surveillance of lung-metastatic cancers and lymphatic metastasis of cancer cells. To our knowledge, this is the first imaging of lymph flow and leukocyte migration through intact pulmonary lymphatics. This approach will enable studies of protective and maladaptive processes unfolding within the lungs and in other previously inaccessible locations.
- Open Access
- 4 December 2023
- Published by Springer Nature in Nature Immunology
- Vol. 25 (1) , 142-154
Dynamic encounters with red blood cells trigger splenic marginal zone B cell retention and function
Spleen marginal zone (MZ) B cells are important for antibody responses against blood-borne antigens. The signals they use to detect exposure to blood are not well defined. Here, using intravital two-photon microscopy in mice, we observe transient contacts between MZ B cells and red blood cells that are in flow. We show that MZ B cells use adhesion G-protein-coupled receptor ADGRE5 (CD97) for retention in the spleen. CD97 function in MZ B cells depends on its ability to undergo autoproteolytic cleavage and signaling via Gα13 and ARHGEF1. Red blood cell expression of the CD97 ligand CD55 is required for MZ B cell homeostasis. Applying a pulling force on CD97-transfected cells using an optical C-trap and CD55+ beads leads to accumulation of active RhoA and membrane retraction. Finally, we show that CD97 deficiency leads to a reduced T cell-independent IgM response. Thus, our studies provide evidence that MZ B cells use mechanosensing to position in a manner that enhances antibody responses against blood-borne antigens.
- 4 December 2023
- Published by Springer Nature in Nature Immunology
- Vol. 25 (1) , 142-154
Open AccessDynamic encounters with red blood cells trigger splenic marginal zone B cell retention and function
Spleen marginal zone (MZ) B cells are important for antibody responses against blood-borne antigens. The signals they use to detect exposure to blood are not well defined. Here, using intravital two-photon microscopy in mice, we observe transient contacts between MZ B cells and red blood cells that are in flow. We show that MZ B cells use adhesion G-protein-coupled receptor ADGRE5 (CD97) for retention in the spleen. CD97 function in MZ B cells depends on its ability to undergo autoproteolytic cleavage and signaling via Gα13 and ARHGEF1. Red blood cell expression of the CD97 ligand CD55 is required for MZ B cell homeostasis. Applying a pulling force on CD97-transfected cells using an optical C-trap and CD55+ beads leads to accumulation of active RhoA and membrane retraction. Finally, we show that CD97 deficiency leads to a reduced T cell-independent IgM response. Thus, our studies provide evidence that MZ B cells use mechanosensing to position in a manner that enhances antibody responses against blood-borne antigens.
- 11 February 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 375 (6581) , 629-+
CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells
Dendritic cells (DCs) are crucial for initiating adaptive immune responses. However, the factors that control DC positioning and homeostasis are incompletely understood. We found that type-2 conventional DCs (cDC2s) in the spleen depend on Gα 13 and adhesion G protein–coupled receptor family member-E5 (Adgre5, or CD97) for positioning in blood-exposed locations. CD97 function required its autoproteolytic cleavage. CD55 is a CD97 ligand, and cDC2 interaction with CD55-expressing red blood cells (RBCs) under shear stress conditions caused extraction of the regulatory CD97 N-terminal fragment. Deficiency in CD55-CD97 signaling led to loss of splenic cDC2s into the circulation and defective lymphocyte responses to blood-borne antigens. Thus, CD97 mechanosensing of RBCs establishes a migration and gene expression program that optimizes the antigen capture and presentation functions of splenic cDC2s.
- 11 February 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 375 (6581) , 629-+
CD97 promotes spleen dendritic cell homeostasis through the mechanosensing of red blood cells
Dendritic cells (DCs) are crucial for initiating adaptive immune responses. However, the factors that control DC positioning and homeostasis are incompletely understood. We found that type-2 conventional DCs (cDC2s) in the spleen depend on Gα 13 and adhesion G protein–coupled receptor family member-E5 (Adgre5, or CD97) for positioning in blood-exposed locations. CD97 function required its autoproteolytic cleavage. CD55 is a CD97 ligand, and cDC2 interaction with CD55-expressing red blood cells (RBCs) under shear stress conditions caused extraction of the regulatory CD97 N-terminal fragment. Deficiency in CD55-CD97 signaling led to loss of splenic cDC2s into the circulation and defective lymphocyte responses to blood-borne antigens. Thus, CD97 mechanosensing of RBCs establishes a migration and gene expression program that optimizes the antigen capture and presentation functions of splenic cDC2s.